The clinical significance of tumor progression: Breast cancer as a model

Cancer Journal

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Hellman, Samuel ^a   Heimann, Ruth ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; BREAST CANCER; CANCER GROWTH; CANCER INVASION; DISEASE COURSE; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SHORT SURVEY;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; NEOPLASM STAGING; PROGNOSIS;

EID: 0033931460     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Bull 1984-1985; 4:297.
2. Keynes G. Carcinoma of the breast, the unorthodox view. Proc Cardiff M Soc 1954;40.
3. Crile G Jr. A Biological Consideration of the Treatment of Breast Cancer. Springfield, IL: Thomas, 1967.
4. Fisher B. Laboratory and clinical research in breast cancer - A personal adventure: The David A. Karnovsky Memorial Lecture. Cancer Res 1980;40:3863-3874.
5. Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer. J Clin Oncol 1998;16:2686-2692.
6. Quiet CA, Ferguson DJ, Weichselbaum RR et al. Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol 1996;14:3105-3111.
7. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin One 1994;12:2229-2234.
8. Heimann R, Ferguson D, Powers C et al. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl Cancer Inst 1996;88:1764-1769.
9. Heimann R, Ferguson D, Gray S et al. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat 1998;52:147-158.
10. Heimann R, Ferguson D, Hellman S. The relationship of nm23 and angiogenesis to the metastatic propensity of node-negative breast cancer. Cancer Res 1998;58:2766-2771.
11. Heimann R, Lan F, McBride R. Separating favorable from unfavorable prognostic markers in breast cancer: The role of e-cadherin. Cancer Res 2000;60:298-304.
12. Tabar L, Fagenberg G, Duffy SW et al. Update of the Swedish two-country program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:37-59.
13. Heimann R, Bradley J, Hellman S. The benefits of mammography are not limited to women of ages older than 50 years. Cancer 1998;82:2221-2226.
14. Heimann R, Hellman S. Clinical progression of breast cancer: what to expect and when to expect it. J Clin Oncol 2000: 18:591-599.